{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T16:27:36Z","timestamp":1784651256093,"version":"3.55.0"},"reference-count":56,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007206","name":"Vanderbilt Institute for Clinical and Translational Research","doi-asserted-by":"publisher","award":["UL1 TR000445"],"award-info":[{"award-number":["UL1 TR000445"]}],"id":[{"id":"10.13039\/100007206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006292","name":"Infectious Diseases Society of America","doi-asserted-by":"publisher","award":["G.E.R.M. Award"],"award-info":[{"award-number":["G.E.R.M. Award"]}],"id":[{"id":"10.13039\/100006292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 MH113438"],"award-info":[{"award-number":["R01 MH113438"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tennessee Center for AIDS Research","award":["P30 AI110527"],"award-info":[{"award-number":["P30 AI110527"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Prim Care Community Health"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction\/Objectives:<\/jats:title>\n                    <jats:p>Pre-exposure prophylaxis (PrEP) use in the southern United States is low despite its effectiveness in preventing HIV acquisition and high regional HIV prevalence. Our objectives were to assess PrEP knowledge, attitudes, and prescribing practices among Tennessee primary care providers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We developed an anonymous cross-sectional electronic survey from March to November 2019. Survey development was guided by the Capability, Opportunity, Motivation, and Behavior framework and refined through piloting and interviews. Participants included members of professional society and health center listservs licensed to practice in Tennessee. Respondents were excluded if they did not complete the question regarding PrEP prescription in the previous year or were not in a position to prescribe PrEP (e.g., hospital medicine). Metrics included PrEP prescription in the preceding year, PrEP knowledge scores (range 0-8), provider attitudes about PrEP, and provider and practice characteristics. Knowledge scores and categorical variables were compared across PrEP prescriber status with Wilcoxon rank-sum and Fisher\u2019s exact tests, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of 147 survey responses, 99 were included and 43 (43%) reported PrEP prescription in the preceding year. Compared with non-prescribers: prescribers had higher median PrEP knowledge scores (7.3 vs 5.6, P\u2009&lt;\u2009.01), a higher proportion had self-reported patient PrEP inquiries (95% vs 21%, P\u2009&lt;\u2009.01), and a higher proportion had self-reported good or excellent ability to take a sexual history (83% vs 58%, P\u2009=\u2009.01) and comfort taking a sexual history (92% vs 63%, P\u2009&lt;\u2009.01) from men who have sex with men, a subgroup with high HIV risk. Most respondents felt obligated to provide PrEP (65%), and felt all primary care providers should provide PrEP (63%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>PrEP provision is significantly associated with PrEP knowledge, patient PrEP inquiries, and provider sexual history taking ability and comfort. Future research should evaluate temporal relationships between these associations and PrEP prescription as potential routes to increase PrEP provision.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/2150132720984416","type":"journal-article","created":{"date-parts":[[2020,12,26]],"date-time":"2020-12-26T00:24:27Z","timestamp":1608942267000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Tennessee Healthcare Provider Practices, Attitudes, and Knowledge Around HIV Pre-Exposure Prophylaxis"],"prefix":"10.1177","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4099-157X","authenticated-orcid":false,"given":"Emily","family":"Moore","sequence":"first","affiliation":[{"name":"Vanderbilt University School of Medicine, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean G.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Alexander","sequence":"additional","affiliation":[{"name":"Meharry Medical College, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Luther","sequence":"additional","affiliation":[{"name":"Nashville CARES, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cooper","sequence":"additional","affiliation":[{"name":"Meharry Medical College, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F.","family":"Rebeiro","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn D.","family":"Zuckerman","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Hargreaves","sequence":"additional","affiliation":[{"name":"Meharry Medical College, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassem","family":"Bourgi","sequence":"additional","affiliation":[{"name":"Indiana University School of Medicine, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Schlundt","sequence":"additional","affiliation":[{"name":"Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kemberlee","family":"Bonnet","sequence":"additional","affiliation":[{"name":"Vanderbilt University, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April C.","family":"Pettit","sequence":"additional","affiliation":[{"name":"Vanderbilt University Medical Center, Nashville, TN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,12,25]]},"reference":[{"key":"bibr1-2150132720984416","unstructured":"Johnson S, Dailey A, Johnson AS, et al. HIV surveillance report, 2018 (preliminary); Vol. 30. Published November 2019. Accessed April 28, 2020. http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html"},{"key":"bibr2-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.1343"},{"key":"bibr3-2150132720984416","unstructured":"Centers for Disease Control and Prevention. CDC statement on FDA approval of drug for HIV prevention. Published July 16, 2012. Accessed April 28, 2020. https:\/\/www.cdc.gov\/nchhstp\/newsroom\/2012\/fda-approvesdrugstatement.html"},{"key":"bibr4-2150132720984416","unstructured":"U.S. Food and Drug Administration. FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic. Published 2019. Accessed April 3, 2020. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic"},{"key":"bibr5-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(14)70847-3"},{"key":"bibr6-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2015.4683"},{"key":"bibr7-2150132720984416","unstructured":"Centers for Disease Control and Prevention. Effectiveness of HIV prevention strategies to reduce the risk of acquiring or transmitting HIV. Published 2019. Accessed April 28, 2020. https:\/\/www.cdc.gov\/hiv\/risk\/estimates\/preventionstrategies.html"},{"key":"bibr8-2150132720984416","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6446a4"},{"key":"bibr9-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001251"},{"key":"bibr10-2150132720984416","first-page":"515","volume":"30","author":"Hood JE","year":"2016","journal-title":"AIDS"},{"key":"bibr11-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-015-1237-1"},{"key":"bibr12-2150132720984416","unstructured":"AIDSVu. Mapping PrEP: first ever data on PrEP users across the U.S\/. Published March 6, 2018. Accessed April 28, 2020. https:\/\/aidsvu.org\/prep"},{"key":"bibr13-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001546"},{"key":"bibr14-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2018.06.009"},{"key":"bibr15-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2018.05.006"},{"key":"bibr16-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2018.06.005"},{"key":"bibr17-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001098"},{"key":"bibr18-2150132720984416","unstructured":"Kelman B. Nashville\u2019s needle exchange was illegal for years. Now it\u2019s legit. Published June 13, 2018. Accessed November 10, 2020. https:\/\/www.tennessean.com\/story\/money\/industries\/health-care\/2018\/06\/13\/nashville-needle-exchange-streetworks-tennessee-first-legal-syringe-program\/602656002\/"},{"key":"bibr19-2150132720984416","first-page":"3","volume":"1","author":"Mistler CB","year":"2020","journal-title":"AIDS Behav"},{"key":"bibr20-2150132720984416","unstructured":"U.S. Department of Health & Human Services. What is \u2018ending the HIV epidemic: a plan for America\u2019? Published October 14, 2020. Accessed December 16, 2020. https:\/\/www.hiv.gov\/federal-response\/ending-the-hiv-epidemic\/overview"},{"key":"bibr21-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e31824f1a1b"},{"key":"bibr22-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2017.1384534"},{"key":"bibr23-2150132720984416","unstructured":"Centers for Disease Control and Prevention. US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142017 Update: a clinical practice guideline. Published March 2018. Accessed April 28, 2020. https:\/\/www.cdc.gov\/hiv\/pdf\/risk\/prep\/cdc-hiv-prep-guidelines-2017.pdf"},{"key":"bibr24-2150132720984416","unstructured":"U.S. Preventive Services Task Force. Draft recommendation statement: prevention of human immunodeficiency virus (HIV) infection: pre-exposure prophylaxis. Accessed April 28, 2020. https:\/\/www.uspreventiveservicestaskforce.org\/Page\/Document\/draft-recommendation-statement\/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis"},{"key":"bibr25-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.6390"},{"key":"bibr26-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-015-0996-z"},{"key":"bibr27-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004511"},{"key":"bibr28-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-42"},{"key":"bibr29-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"bibr30-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"bibr31-2150132720984416","unstructured":"Tennessee Department of Health. Local and regional health departments. Accessed April 28, 2020. https:\/\/www.tn.gov\/health\/health-program-areas\/localdepartments.html"},{"key":"bibr32-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-016-1625-1"},{"key":"bibr33-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001182"},{"key":"bibr34-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000781"},{"key":"bibr35-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1016\/j.contraception.2015.12.018"},{"key":"bibr36-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1177\/2150132719878526"},{"key":"bibr37-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-014-0839-3"},{"key":"bibr38-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1177\/2325957415600798"},{"key":"bibr39-2150132720984416","unstructured":"U.S. Preventive Services Task Force. Prevention of human immunodeficiency virus (HIV) infection: preexposure prophylaxis. Published June 11, 2019. Accessed May 11, 2020. https:\/\/www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis"},{"key":"bibr40-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3903-z"},{"key":"bibr41-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132398"},{"key":"bibr42-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05475-9"},{"key":"bibr43-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-016-3899-4"},{"key":"bibr44-2150132720984416","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2017.304061"},{"key":"bibr45-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.13.1458"},{"key":"bibr46-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s13178-012-0105-2"},{"key":"bibr47-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1089\/lgbt.2013.0046"},{"key":"bibr48-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-011-1711-z"},{"key":"bibr49-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1111\/jsm.12448"},{"key":"bibr50-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1111\/j.1743-6109.2012.02702.x"},{"key":"bibr51-2150132720984416","doi-asserted-by":"publisher","DOI":"10.7326\/M17-2082"},{"key":"bibr52-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-007-9299-3"},{"key":"bibr53-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157324"},{"key":"bibr54-2150132720984416","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6837a2"},{"key":"bibr55-2150132720984416","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001579"},{"key":"bibr56-2150132720984416","unstructured":"Tennessee Department of Health. Tennessee HIV epidemiological profile 2018. Published January 2020. Accessed November 10, 2020. https:\/\/www.tn.gov\/content\/dam\/tn\/health\/program-areas\/hiv\/Tennessee-HIV-Epidemiological-Profile-2018.pdf"}],"container-title":["Journal of Primary Care &amp; Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2150132720984416","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2150132720984416","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2150132720984416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:22:27Z","timestamp":1777508547000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2150132720984416"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":56,"alternative-id":["10.1177\/2150132720984416"],"URL":"https:\/\/doi.org\/10.1177\/2150132720984416","relation":{},"ISSN":["2150-1319","2150-1327"],"issn-type":[{"value":"2150-1319","type":"print"},{"value":"2150-1327","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]},"article-number":"2150132720984416"}}